Original ArticlesTranspupillary thermotherapy for circumscribed choroidal hemangiomas☆
Section snippets
Patients and methods
A prospective, consecutive, nonrandomized clinical study was conducted from June 1996 through July 1997 in all patients with circumscribed choroidal hemangiomas treated with TTT at the Instituto de Microcirugia Ocular.
The patient data included age, race, visual symptoms, and visual acuity (VA) at the initial examination. The tumor data included the largest tumor base (in millimeters, measured by indirect ophthalmoscopy), the greatest tumor thickness (in millimeters, measured by A- and B-scan
Results
From June 1996 through July 1997, 18 patients with circumscribed choroidal hemangiomas were treated using TTT. Of these, three patients had undergone pars plana vitrectomy before TTT, because the circumscribed choroidal hemangioma was associated with a bullous retinal detachment. Another three of the 18 circumscribed choroidal hemangiomas had been previously treated with argon laser, and in one patient the tumor thickness was 4.5 mm. At the time of data collection, three patients had a
Discussion
The management of circumscribed choroidal hemangiomas varies with the severity of symptoms and the presence or absence of exudative retinal detachment. If the patient is asymptomatic, no treatment is necessary. Because circumscribed choroidal hemangiomas rarely increase in size and may remain quiescent for months or years, the best treatment option may be observation every 6 months. In patients with visual loss because of exudative macular detachment, treatment should be considered.
Various
References (24)
- et al.
Microwave thermotherapy for choroidal hemangioma
Am J Ophthalmol
(1991) - et al.
Cobalt-60 treatment of choroidal hemangiomas
Am J Ophthalmol
(1996) - et al.
Treatment of circumscribed choroidal hemangiomas
Ophthalmology
(1982) - et al.
Ultrasonic hyperthermia and radiation in the management of intraocular malignant melanoma
Am J Ophthalmol
(1986) - et al.
Histopathologic effects of ultrasonically induced hyperthermia in intraocular malignant melanoma
Ophthalmology
(1988) - et al.
Transpupillary thermotherapy in the management of choroidal melanoma
Ophthalmology
(1996) - et al.
Transpupillary thermotherapy for choroidal melanoma. Tumor control and visual results in 100 consecutive cases
Ophthalmology
(1998) - et al.
Circumscribed choroidal hemangiomas
Arch Ophthalmol
(1989) Circumscribed choroidal hemangioma
Intraocular tumors. I. Bilateral hemangioma of the choroid
Arch Ophthalmol
Cited by (87)
Photodynamic therapy in the treatment of circumscribed choroidal hemangioma: Current perspectives
2022, Photodiagnosis and Photodynamic TherapyCitation Excerpt :A variety of treatment modalities principally aiming at regression of the lesion and reduction of the leakage have been used for these vascular lesions. The treatment options include laser photocoagulation, cryotherapy, radiotherapy, proton beam radiotherapy, external beam radiotherapy, plaque radiotherapy, transpupillary thermotherapy and more recently photodynamic therapy with verteporfin has been used [11–24]. These treatments are associated with the inherent risk of damaging the overlying retina and most importantly; the optic nerve.
Circumscribed choroidal hemangioma: Comparative efficacy of transpupillary thermotherapy, indocyanine green-enhanced transpupillary thermotherapy, and photodynamic therapy and analysis of baseline clinical features effecting treatment outcomes
2021, Photodiagnosis and Photodynamic TherapyCitation Excerpt :Decrease in tumor thickness by <20% were found in 37.9%, 40.6%, and 19.2% in TTT, ICG-TTT, and PDT groups respectively at 18 months (p = 0.622, Fig. 4d). Different laser treatment methods including surface laser photocoagulation, TTT, and ICG-TTT have been used in the management of CCH [7–12]. More recently, PDT has become a widely used treatment in CCH but is expensive and may not be available for all patients [13].
Other therapies in CSCR
2019, Central Serous ChorioretinopathyCircumscribed Choroidal Hemangioma
2012, Retina Fifth Edition
- ☆
The authors have no proprietary interest in any aspect of this study.